share_log

华海药业(600521.SH):左乙拉西坦口服溶液获得药品注册证书

Zhejiang Huahai Pharmaceutical (600521.SH): Registration certificate obtained for pharmaceutical oral solution of levetiracetam.

Gelonghui Finance ·  Jul 19 04:56

On July 19, Gelun Hui reported that its subsidiary, Changxing Pharmaceutical Co., Ltd., received the Drug Registration Certificate issued by the National Medical Products Administration (NMPA) for oral solution of Levetiracetam. The oral solution is mainly used as an adjunctive treatment for partial seizures in adult, pediatric and infants over one month old with epilepsy.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment